Drug intelligence / Profile preview

umbilical cord-derived mesenchymal stem cells (Academy of Military Medical Sciences)

Development stage
Unknown
Lead developer
Academy of Military Medical Sciences
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are an investigational cell therapy being developed by the Affiliated Hospital to Academy of Military Medical Sciences for the treatment of acute graft-versus-host disease (aGVHD). These multipotent stem cells possess significant immunomodulatory properties, including the ability to inhibit T-cell proliferation and modulate the activity of various immune cells such as B-cells, natural killer (NK) cells, and dendritic cells. By secreting anti-inflammatory cytokines and promoting a pro-tolerogenic environment, UC-MSCs aim to mitigate the life-threatening immune response seen in aGVHD following allogeneic hematopoietic stem cell transplantation. The therapy is currently being evaluated in Phase I/II clinical trials to assess its safety and efficacy as an off-the-shelf treatment option.

Other names
Human Umbilical Cord Derived MSCUC-MSCs

Beyond the preview

Go deeper on umbilical cord-derived mesenchymal stem cells (Academy of Military Medical Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (Academy of Military Medical Sciences).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call